Neil Woodford. Woodford Investment Management via YouTube
Woodford fallout to blame for shrinking biotech valuations, co-investor says
The IP Group did not have a good first half of the year. And the UK investment company thinks Neil Woodford — its second-largest shareholder …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
